New pill could replace painful injections for deadly tropical disease
NCT ID NCT05957978
Summary
This study tested a new oral medicine called LXE408 against the standard treatment for visceral leishmaniasis, a serious parasitic infection. 52 adults in Ethiopia took either the new pill for 14 days or received standard injections for 17 days. Researchers compared how well each treatment worked and how safe they were, checking patients for up to 6 months.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PRIMARY VISCERAL LEISHMANIASIS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
University of Gondar
Gonder, Ethiopia
Conditions
Explore the condition pages connected to this study.